Swinburne Autism Bio-Research Initiative (SABRI), Faculty of Life and Social Sciences, Swinburne University of Technology, Hawthorn, Victoria, Australia.
Autism Res. 2012 Dec;5(6):419-27. doi: 10.1002/aur.1253. Epub 2012 Sep 20.
Many children with autism spectrum disorders (ASDs) suffer from gastrointestinal problems such as diarrhoea, constipation and abdominal pain. This has stimulated investigations into possible abnormalities of intestinal microbiota in autistic patients. Therefore, we designed this study to identify differences (and/or similarities) in the microbiota of children with autism (without gastrointestinal dysfunction: n = 23; with gastrointestinal dysfunction: n = 28) and their neurotypical siblings (n = 53) who share a similar environment using bacterial tag-encoded FLX amplicon pyrosequencing. Regardless of the diagnosis and sociodemographic characteristics, overall, Firmicutes (70%), Bacteroidetes (20%) and Proteobacteria (4%) were the most dominant phyla in samples. Results did not indicate clinically meaningful differences between groups. The data do not support the hypothesis that the gastrointestinal microbiota of children with ASD plays a role in the symptomatology of ASD. Other explanations for the gastrointestinal dysfunction in this population should be considered including elevated anxiety and self-restricted diets.
许多自闭症谱系障碍(ASD)儿童患有胃肠道问题,如腹泻、便秘和腹痛。这促使人们研究自闭症患者肠道微生物群可能存在的异常。因此,我们设计了这项研究,以使用细菌标签编码 FLX 扩增子焦磷酸测序来确定自闭症儿童(无胃肠道功能障碍:n = 23;有胃肠道功能障碍:n = 28)与其具有相似环境的神经典型兄弟姐妹(n = 53)之间的微生物群差异(和/或相似之处)。无论诊断和社会人口特征如何,总体而言,厚壁菌门(70%)、拟杆菌门(20%)和变形菌门(4%)是样本中最主要的门。结果表明各组之间没有临床意义上的差异。这些数据不支持自闭症儿童的胃肠道微生物群在 ASD 症状中起作用的假设。对于该人群中的胃肠道功能障碍,应该考虑其他解释,包括焦虑升高和自我限制饮食。